Multi-Family Office

Updated:

GISEV Family Office

Giammaria Giuliani and Mario Giuliani launched the firm in 2021 after building pharmaceutical holdings through Giuliani SpA. Achille Severgnini joined as...

GISEV Family Office logo

GISEV Family Office

Giammaria Giuliani and Mario Giuliani launched the firm in 2021 after building pharmaceutical holdings through Giuliani SpA. Achille Severgnini joined as co-founder. The wealth origin traces directly to those holdings rather than external mandates. The firm executes through direct co-investments and SPVs in early-stage and seed rounds. Asset classes include venture growth, real estate, and healthcare services. Confirmed positions involve Cortilia alongside Red Circle Investments and Italian technology rounds with H14. Activity centers on Europe with additional exposure in Monaco through the Mareterra project. No public headcount or AUM figures exist. Adjacent vehicles include Nogra Group in Luxembourg and Fondazione Giuliani per l'arte contemporanea in Rome. Giammaria Giuliani sits on the Hospital for Special Surgery Board of Trustees. The structure separates family capital from client mandates through an integrated multi-family platform rather than a pure single-family vehicle.

General information

Firm type

Multi Family Office

Year founded

2021

Location

Region

Europe

Country

Switzerland

City

Lugano

Corporate office

Lugano, Switzerland

Principals

Giammaria Giuliani

Founder

Mario Giuliani

Founder

Achille Severgnini

Founder

Sector focus

AgriTech & FoodTechHealthcare ServicesDigital HealthSports & Wellness

Frequently asked questions

Who runs investment decisions at GISEV Family Office?

Giammaria Giuliani and Mario Giuliani set the investment direction alongside Achille Severgnini. Decisions center on direct co-investments in early-stage European companies.

How does GISEV Family Office source proprietary deal flow?

The firm draws on long-standing relationships with co-investors including H14 and Red Circle Investments. It also leverages the Giuliani family's pharmaceutical network across Italy and Switzerland.

Is GISEV Family Office structured as a single family office or does it operate more like a venture firm?

It functions as a multi-family office that accepts external client capital while deploying its own family balance sheet into venture and real estate.

Does GISEV Family Office participate in fund commitments or only direct deals?

The firm focuses on direct co-investments and SPVs rather than blind-pool fund commitments.

Where does the underlying wealth come from?

The capital originates from the Giuliani family's pharmaceutical holdings built through Giuliani SpA.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Lugano Multi Family Office profiles